Catalyst Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors
The stock's fall snapped a three-day winning streak.
Catalyst Pharmaceuticals Inc. stock outperforms competitors on strong trading day
Shares of Catalyst Pharmaceuticals Inc. CPRX rose 1.34% to $23.40 Wednesday, on what proved to be an all-around favorable ...
Fintel on MSN6d
Baird Initiates Coverage of Catalyst Pharmaceuticals (CPRX) with Outperform Recommendation
Fintel reports that on February 4, 2025, Baird initiated coverage of Catalyst Pharmaceuticals (NasdaqCM:CPRX) with a ...
abrdn plc Buys New Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) in the fourth quarter, HoldingsChannel.com reports. The institutional investor bought 484,666 shares of the biopharmaceutical company’s stock ...
Catalyst Pharmaceuticals initiated with an Outperform at Baird
Baird analyst Joel Beatty last night initiated coverage of Catalyst Pharmaceuticals (CPRX) with an Outperform rating and $28 price target ...
Benzinga.com7d
Beyond The Numbers: 6 Analysts Discuss Catalyst Pharmaceuticals Stock
Analysts' ratings for Catalyst Pharmaceuticals CPRX over the last quarter vary from bullish to bearish, as provided by 6 analysts. The following table summarizes their recent ratings, shedding ...
Baird starts Catalyst Pharma with Outperform, $28 target
Baird initiated coverage on Catalyst Pharmaceutical Partners (NASDAQ:CPRX) with an Outperform rating and set a price target ...
Your Story2h
IXP launches Rs 200 Cr fund to support early-stage biotech startups
The fund aims to build a portfolio of 20-25 companies that address gaps in services and products across pharmaceuticals, ...
Pharmabiz4h
IXP launches maiden Rs. 200 crore to fuel biotech innovation
Our Bureau, Bengaluru Tuesday, February 11, 2025, 11:40 Hrs [IST] IXP (Innovation Acceleration Platform), a lifescien ...